Sofinnova Investments related stories
All articles and analysis
VCs on the Move: Google, Felicis, DFJ and Other Venture Firms Ramp UpFrom CrunchFund to Google; DFJ hires Facebook exec; and Facebook board member to step down
First Shot Therapy Completes Series A FundingFirst Aid Shot Therapy ("F.A.S.T.") said on Wednesday that it has completed a Series A financing round. No financial terms were disclosed. Sofinnova Ventures led the round. According to F.A.S.T., the funds will be used for the company's U.S. product launch beginning this summer. F.A.S.T, which is headquartered in Burlingame, Calif., is a consumer healthcare company focused on over-the-counter therapies in liquid form.
- NVCA Elects Josh Green as Chairman of the Board
The National Venture Capital Association has elected Josh Green to serve as its 2013-2014 chairman of the board of directors. Green is general partner of Mohr Davidow Ventures. Also VCA added the following as new directors to its board: Scott Kupor, Andreessen Horowitz; Sue Siegel, GE healthymagination; John Backus, New Atlantic Ventures; Art Pappas, Pappas Ventures; Mark Leschly, Rho Capital Partners; and Jim Healy, Sofinnova Ventures. And NVCA also named Scott Sandell, general partner at New Enterprise Associates, as chair-elect for the 2014-2015 year.
- Akkaraju Joins Sofinnova Ventures
Srinivas Akkaraju, M.D., Ph.D. has joined Sofinnova Ventures as a general partner while Anand Mehra , M.D., was promoted to General Partner. Dr. Akkaraju was most recently a Managing Director at New Leaf Venture Partners. Sofinnova is a Menlo Park investment firm.
Sofinnova Partners Bucks Trend, Raises Life Science FundParis firm drops IT, raises its seventh fund, focused solely on life sciences
- Catching Up With Eric Benhamou
Eight years after founding his early-stage venture firm, the longtime 3Com CEO has begun looking for late-stage Russian deals
- Guavus Acquires Neuralitic Systems
Guavus, a provider of big data analytics solutions, has acquired Neuralitic Systems, a mobile data monetization and marketing analytics experts serving the telecommunications industry. Guavus is backed by Investor Growth Capital, QuestMark Partners and previous investors Artiman Ventures, Sofinnova Ventures and Intel Capital.
- Guavus Raises $30m Funding
Guavus, a provider of big data analytics solutions has closed a $30 million round of new funding. Investor Growth Capital led the round with participation from QuestMark Partners and previous investors Artiman Ventures, Sofinnova Ventures and Intel Capital.
- Marinus Pharmaceuticals Adds $21M Series C
Marinus Pharmaceuticals Inc., has added $21 million in Series C financing from Domain Associates, RusnanoMedInvest, Canaan Partners, Sofinnova Ventures and Foundation Medical Partners. Branford, Conn.-based Marinus is the developer of the neuroactive steroid Ganaxolone.
- Biotech bang for buck(3)
Biotechnology and life sciences companies require significant investment capital, and multi-million dollar investment rounds have recently grabbed headlines. But depending on the technologies being developed, the underlying research can be more or less expensive, providing many types of opportunities for investors. David Rapp spoke with leading biotech investors to learn more.